Mohamed Nabil Abd Al Moaty

6PUBLICATIONS
14CO-AUTHORS
Biomolecular modelling and designMolecular targetsBiologically active moleculesNanomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 28, 2026
Development of new quinoline-triazole based hybrids: synthesis, nano-encapsulation, DFT calculations, and evaluation of antidiabetic and antioxidant activity.

|May 20, 2024
Triggering Breast Cancer Apoptosis via Cyclin-Dependent Kinase Inhibition and DNA Damage by Novel Pyrimidinone and 1,2,4-Triazolo[4,3-a]pyrimidinone Derivatives.

Mohamed N Abd Al Moaty, Yeldez El Kilany, Laila F Awad

|Oct 22, 2023
Discovery of novel benzimidazole acyclic C-nucleoside DNA intercalators halting breast cancer growth.

Mohamed N Abd Al Moaty, Yeldez El Kilany, Laila Fathy Awad

|Sep 23, 2022
Molasses-Silver Nanoparticles: Synthesis, Optimization, Characterization, and Antibiofilm Activity.

Rabab A Dorgham, Mohamed N Abd Al Moaty, Khim Phin Chong

|Jun 27, 2022
Harnessing ROS-Induced Oxidative Stress for Halting Colorectal Cancer via Thiazolidinedione-Based SOD Inhibitors.

Mohamed Nabil Abd Al Moaty, El Sayed H El Ashry, Laila Fathy Awad

|Apr 23, 2022
Enhancing the Anticancer Potential of Targeting Tumor-Associated Metalloenzymes via VEGFR Inhibition by New Triazolo[4,3-a]pyrimidinone Acyclo C-Nucleosides Multitarget Agents.

Mohamed Nabil Abd Al Moaty, El Sayed Helmy El Ashry, Laila Fathy Awad

Pageof 1

Frequent Collaborators

3 joint publications

Laila Fathy Awad

2 joint publications

Saied M Soliman

2 joint publications

Assem Barakat

1 joint publications

Khim Phin Chong